George Gould - Aspen Aerogels Vice President - Research and Development
| ASPN Stock | USD 15.05 0.74 5.17% |
President
Dr. George L. Gould Ph.D., is the Vice President Research and Development of the Company. He was with the Company since inception in 2001. Prior to this role, he served in a variety of positions with the Company, most recently as the Director, Research and Development from February 2009 to April 2011 and Director, Research from June 2005 to February 2009. Prior to joining the Company, Dr. Gould was employed by the predecessor, Aspen Systems. Prior to joining Aspen Systems, Dr. Gould was a chemistry professor at the University of Illinois at Chicago since 2018.
| Age | 56 |
| Tenure | 6 years |
| Professional Marks | Ph.D |
| Address | Building B, Northborough, MA, United States, 01532 |
| Phone | 508 691 1111 |
| Web | https://www.aerogel.com |
Aspen Aerogels Management Efficiency
The company has return on total asset (ROA) of 0.0433 % which means that it generated a profit of $0.0433 on every $100 spent on assets. This is way below average. Aspen Aerogels' management efficiency ratios could be used to measure how well Aspen Aerogels manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to drop to -0.07. In addition to that, Return On Capital Employed is likely to drop to -0.08. At this time, Aspen Aerogels' Net Tangible Assets are very stable compared to the past year. As of the 26th of November 2024, Debt To Assets is likely to grow to 0.33, while Return On Tangible Assets are likely to drop (0.07).Similar Executives
| Showing other executives | PRESIDENT Age | ||
| John Heneghan | ASGN Inc | N/A | |
| Adam Wyll | American Assets Trust | 49 | |
| Paul Tivnan | Ardmore Shpng | 41 | |
| Todd Hornsby | Apyx Medical | 47 | |
| Theodore Hanson | ASGN Inc | 56 | |
| Sean Casey | ASGN Inc | N/A | |
| Jerry Gammieri | American Assets Trust | 59 | |
| Robert Barton | American Assets Trust | 67 | |
| Edward Pierce | ASGN Inc | 67 | |
| Randolph Blazer | ASGN Inc | 73 | |
| James Brill | ASGN Inc | 73 | |
| Moshe Citronowicz | Apyx Medical | 71 | |
| Mark Cameron | Ardmore Shpng | 58 | |
| George Wilson | ASGN Inc | 62 | |
| Jennifer Painter | ASGN Inc | 55 | |
Management Performance
| Return On Equity | 0.0033 | ||||
| Return On Asset | 0.0433 |
Aspen Aerogels Leadership Team
Elected by the shareholders, the Aspen Aerogels' board of directors comprises two types of representatives: Aspen Aerogels inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aspen. The board's role is to monitor Aspen Aerogels' management team and ensure that shareholders' interests are well served. Aspen Aerogels' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aspen Aerogels' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Mitchell, Independent Director | ||
| John Fairbanks, Chief Financial Officer, Vice President, Treasurer | ||
| Santhosh Daniel, Chief Officer | ||
| Corby Whitaker, Senior Vice President of Sales and Marketing | ||
| Gregg Landes, Senior Vice President, Operations and Strategic Development | ||
| Jeffrey Ball, VP of Operations | ||
| Kelley Conte, Vice President of Human Resources | ||
| Keith Schilling, Senior Technology | ||
| Rebecca Blalock, Independent Director | ||
| Robert Gervis, Independent Director | ||
| Richard Reilly, Independent Director | ||
| William Noglows, Independent Chairman of the Board | ||
| George Gould, Vice President - Research and Development | ||
| JD Llm, Chief Officer | ||
| Laura GuerrantOiye, Vice Communications | ||
| Stephanie Pittman, Chief Officer | ||
| Donald Young, President, Chief Executive Officer, Director | ||
| Neal Baranosky, Senior Finance | ||
| Ricardo Rodriguez, Chief Financial Officer, Senior Vice President, Treasurer | ||
| Steve Mitchell, Independent Director | ||
| Mark Noetzel, Independent Chairman of the Board | ||
| Virginia Johnson, General Officer |
Aspen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aspen Aerogels a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0033 | ||||
| Return On Asset | 0.0433 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 1.33 B | ||||
| Shares Outstanding | 82.05 M | ||||
| Shares Owned By Insiders | 1.62 % | ||||
| Shares Owned By Institutions | 89.86 % | ||||
| Number Of Shares Shorted | 8.51 M | ||||
| Price To Earning | (4.28) X |
Pair Trading with Aspen Aerogels
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspen Aerogels position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspen Aerogels will appreciate offsetting losses from the drop in the long position's value.Moving against Aspen Stock
| 0.86 | AWI | Armstrong World Indu | PairCorr |
| 0.82 | AAON | AAON Inc | PairCorr |
| 0.77 | JCI | Johnson Controls Int Sell-off Trend | PairCorr |
| 0.77 | APOG | Apogee Enterprises | PairCorr |
| 0.75 | OC | Owens Corning | PairCorr |
The ability to find closely correlated positions to Aspen Aerogels could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspen Aerogels when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspen Aerogels - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspen Aerogels to buy it.
The correlation of Aspen Aerogels is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspen Aerogels moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspen Aerogels moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspen Aerogels can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspen Aerogels. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Aspen Stock, please use our How to Invest in Aspen Aerogels guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspen Aerogels. If investors know Aspen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspen Aerogels listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.02 | Revenue Per Share 5.532 | Quarterly Revenue Growth 0.931 | Return On Assets 0.0433 | Return On Equity 0.0033 |
The market value of Aspen Aerogels is measured differently than its book value, which is the value of Aspen that is recorded on the company's balance sheet. Investors also form their own opinion of Aspen Aerogels' value that differs from its market value or its book value, called intrinsic value, which is Aspen Aerogels' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspen Aerogels' market value can be influenced by many factors that don't directly affect Aspen Aerogels' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspen Aerogels' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspen Aerogels is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspen Aerogels' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.